Author: Matt Batcheldor
Oct. 7, 2021—Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.
Oct. 7, 2021—Vanderbilt's JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure.
Sep. 23, 2021—Vanderbilt's Lynne Warner Stevenson, MD, has received the Lifetime Achievement Award from the Heart Failure Society of America.
Sep. 15, 2021—Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.
Sep. 9, 2021—Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.
Sep. 2, 2021—Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.
Aug. 26, 2021—All Coleen Leszczynski ever wanted was to be normal. Born with a congenital heart disease (CHD), she labored to breathe, having only three-quarters the oxygen capacity of a healthy person. Still, she fought to live, serving as a cardiac nurse in her native Philadelphia area for more than 16 years. She wanted to help people like her.
Aug. 26, 2021—Mike DeFoe has been named executive director of Finance for Vanderbilt Bedford Hospital.
Aug. 19, 2021—Over the last two years at Vanderbilt University Medical Center, Transplant Pharmacy technician Sarah Osman, CPhT, has become very familiar with the process of organ transplantation.